NYSE: KMBKimberly Clark Corp Stock
$130.48+3.11 (+2.44%)
Updated Mar 24, 2023
KMB Price
$130.48
Fair Value Price
N/A
Market Cap
$44.04B
52 Week Low
$108.74
52 Week High
$144.53
P/E
22.77x
P/B
80.51x
P/S
2.27x
PEG
1.81x
Dividend Yield
3.57%
Revenue
$20.18B
Earnings
$1.93B
Gross Margin
30.8%
Operating Margin
13.44%
Profit Margin
9.6%
Debt to Equity
31.57
Operating Cash Flow
$3B
Beta
0.46
Next Earnings
Apr 20, 2023
Ex-Dividend
Mar 9, 2023
Next Dividend
Apr 4, 2023
KMB Overview
Kimberly-Clark Corporation manufactures personal care and consumer tissue products in the U.S. and internationally. Personal care offerings include disposable diapers, baby wipes, feminine and incontinence care products, and related products. Its brands names are Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and others. Tissue products offered include facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve brand names. Kimberly-Clark was founded in 1872 and is headquartered in Dallas, TX.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KMB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KMB ($130.48) is trading above its intrinsic value of $60.45, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KMB is poor value based on its earnings relative to its share price (22.77x), compared to the US market average (21.37x)
P/E vs Market Valuation
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more KMB due diligence checks available for Premium users.
Be the first to know about important KMB news, forecast changes, insider trades & much more!
KMB News
Valuation
KMB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.77x
Industry
32.43x
Market
21.37x
KMB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
KMB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
KMB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
80.51x
Industry
7.15x
KMB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KMB price to earnings growth (PEG)
For valuing profitable companies with growth potential
KMB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
KMB's financial health
Profit margin
Revenue
$5.0B
Net Income
$507.0M
Profit Margin
10.2%
KMB's Earnings (EBIT) of $2.71B... subscribe to Premium to read more.
Interest Coverage Financials
KMB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$18.0B
Liabilities
$17.3B
Debt to equity
31.57
KMB's short-term liabilities ($7.33B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KMB's long-term liabilities ($9.94B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KMB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
KMB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$991.0M
Investing
-$268.0M
Financing
-$651.0M
KMB's operating cash flow ($2.73B)... subscribe to Premium to read more.
Debt Coverage Financials
KMB vs Household & Personal Product Stocks
Kimberly Clark Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.